Trial 42756493CAN2002 Ragnar

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

42756493CAN2002 Ragnar

Full title

A Phase 2 Study of Erdafitinib in Subjects with Advanced Solid Tumors and FGFR Gene Alterations

NCT number

NCT04083976

Responsible organization

3. Med 3. Med Ismaninger Str. 22 81675 München Germany

Classification	Code	Description
-		Other tumors

Phase

Status

Recruitment finished

Votes

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Zielgerichtet - Therapieart: palliativ

	Function	Prename	Surname	Organization
	Responsible contact	Sylvie	Lorenzen	3. Med 3. Med Ismaninger Str. 22 81675 München Germany